Lovelace Health System recently hired the 32 employees of Hematology Oncology Associates of New Mexico as part of their expanding cancer care services. The Albuquerque Journal covered the story on April 4, 2017.
ALBUQUERQUE – April 3, 2017 – Steven Henao, M.D., chief vascular surgeon of New Mexico Heart Institute performed the first implant of the Ovation Alto™ Abdominal Stent Graft system in a patient on Thursday, March 30 at Heart Hospital of New Mexico at Lovelace Medical Center.
The Ovation Alto is manufactured by Endologix Corporation and is designed to treat abdominal aortic aneurysm (AAA).
Lovelace Medical Group opened the new Lovelace Neurosciences Center at 500 Walter St. NE, Suite 401 on March 20. Steven Sinovic at the Albuquerque Journal interviewed John Cruickshank, D.O., CEO of Lovelace Medical Group, regarding the new clinic and what it means for patients to have neurosurgeons, neurologists and other providers in close proximity.
In January, 2017, Lovelace Medical Group opened a new clinic in the Las Estancias development of Albuquerque's South Valley. The new location is becoming a hub of economic development in the area, as reported by The Albuquerque Journal's Steve Sinovic.
ALBUQUERQUE – March 8, 2017 – Physicians at Heart Hospital of New Mexico at Lovelace Medical Center recently implanted the WATCHMAN™ Left Atrial Appendage Closure (LAAC) device in a New Mexico patient.
The device offers patients with non-valvular atrial fibrillation (AF) an alternative to long-term Warfarin blood-thinning medication.